Triple combinations regimens for HIV.
D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000480:Alkynes; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D048588:Benzoxazines; D003521:Cyclopropanes; D015224:Dideoxynucleosides / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage; D015337:Multicenter Studies as Topic; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000008:administration & dosage; D010078:Oxazines / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic; D000068698:Tenofovir; D017211:Treatment Failure; D000099227:Abacavir
D000225:Adenine; D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D015224:Dideoxynucleosides; D019259:Lamivudine; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D010078:Oxazines; D000068698:Tenofovir; D000099227:Abacavir; C098320:efavirenz